1 study found for:    17950857 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)
Condition: Allergic Asthma
Interventions: Drug: AER 001;   Drug: placebo

Indicates status has not been verified in more than two years